Evidence map›Paper›PMID 39416750›Full record

ArticleBJUI compass2024

Machine learning analysis for detecting late recurrence and loss to follow-up after renal cell carcinoma surgery.

Kodai Sato, Tomokazu Sazuka, Takayuki Arai, Hiroaki Sato, Manato Kanesaka, Keisuke Ando, Shinpei Saito, Sangjon Pae, Yasutaka Yamada, Yusuke Imamura and 2 more

Erratum issuedAbstract read
In one paragraph

Article in BJUI compass, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Erratum.BJUI compass · 2024
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Kodai SatoDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.
Tomokazu SazukaDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.ORCID https://orcid.org/0000-0002-8902-7853
Takayuki AraiDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.
Hiroaki SatoDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.ORCID https://orcid.org/0000-0001-6516-2519
Manato KanesakaDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.
Keisuke AndoDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.
Shinpei SaitoDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.ORCID https://orcid.org/0000-0002-9346-0553
Sangjon PaeDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.
Yasutaka YamadaDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.
Yusuke ImamuraDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.
Shinichi SakamotoDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.
Tomohiko IchikawaDepartment of Urology, Graduate School of Medicine Chiba University Chiba Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Renal cell carcinoma (RCC) is shown to have a tendency for late recurrence, occurring 5 or more years after curative surgery. Imaging diagnosis is required for follow-up, and there is no definitive answer as to how long this should continue. Some patients discontinue follow-up visits at their own discretion. How best to predict late recurrence and loss to follow-up (LF) remains unclear. Patients and methods: This study targeted patients diagnosed with non-metastatic RCC who underwent either radical or partial nephrectomy at Chiba University Hospital between 1988 and 2021. Follow-up for patients with RCC is typically lifelong. We used random survival forests (RSFs), a machine learning-based survival analysis method, to predict late recurrence and LF. For verification of prediction accuracy, we applied the time-dependent area under the receiver operating characteristic curve (t-AUC). To analyse the risks of late recurrence and LF, SurvSHAP(t) and partial dependence plots were used. Results: We analysed 1051 cases in this study. Median follow-up was 58.5 (range: 0-376) months. The predictive accuracy of recurrence using RSF was t-AUC 0.806, 0.761, 0.674 and 0.566 at 60, 120, 180 and 240 months postoperatively, respectively. The recurrence risk impact showed a time-dependent increase up to approximately 50 months postoperatively. Beyond 50 months, there were no distinct risk factors characteristic of late recurrence. The predictive accuracy of LF using RSF was t-AUC 0.542, 0.699, 0.685, 0.628 and 0.674 at 60, 120, 180, 240 and 300 months postoperatively, respectively. The risk of LF increased with advancing age beyond 70 years. Conclusion: It is difficult to identify factors that predict late recurrence. For long-term follow-up observation, it is essential to pay particular attention to patients with RCC aged 70 years and above. Establishing frameworks to facilitate collaboration with local hospitals near patients' residences and providing care within the community is necessary.

Indexed as

late recurrenceloss to follow‐upmachine learningrandom survival forestsrenal cell carcinoma

Identifiers

PMID39416750
PMCPMC11479800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.